Prevymis (letermovir) - Merck (MSD)
Telomeropathy: pretransplant and posttransplant considerations for clinicians. (PubMed, Curr Opin Pulm Med) - Mar 27, 2025 - "Management of lung transplant recipients with TBDs requires careful consideration of multiorgan manifestations and individualized management strategies. A multidisciplinary approach incorporating genetics, haematology, and hepatology expertise is increasingly essential for optimal outcomes in this unique population." 
Journal • Cytomegalovirus Infection • Hematological Disorders • Hepatology • Idiopathic Pulmonary Fibrosis • Immunology • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/40145203
 
John A Mackintosh
 
Mar 27, 2025
 
Prev Next